Global Clinical Data Management System (CDMS) Market Overview

The Clinical Data Management System (CDMS) Market is expected to grow at a significant growth rate, and the analysis period is 2022-2028, considering the base year as 2021.

A clinical data management system is a tool that is used in clinical research for the purpose of managing and storing the data of clinical trials. This system stores the data in the form of a case report at the investigator's location. To the reduction of the possibility of errors because of human entry, this system uses various means to verify the data. The clinical data management system can be independent or part of the CTMS (Clinical Trial Management System) function. The function of CTMS with the clinical data management features helps for validation of clinical data, and assists to employ other important activities such as producing patient registries and helping in patient recruitment efforts. The key feature of the CDMS in managing clinical data is producing satisfactory outcomes of clinical research, controlling the data entry, storage, transmission, verifying the data in the highest quality, integrity, and reliability, rapid-tracking a drug's time-to-market, providing better patient experience and outcomes by minimizing time of drug development. Due to these features, their increasing demand in the pharmaceutical sector propels the growth of the clinical data management system market.

Market Dynamics And Factors For Clinical Data Management System (CDMS) Market

Drivers:

Rising Demand for Clinical Data Management Systems in Clinical Trials

The growing demand for clinical data management systems for clinical trials owing to their numerous benefits is a key factor that supports the growth of the market. The benefits such as, it provides a global, controlled, and standardized data repository. The CDMS controls the entire data entry and transmission process and corrected any errors in the data. Other benefits of these tools are they offer flexibility in format, low cost, and their ability to capture extra response set information, build trust with regulatory authorities, and remotely monitor the data. The clinical data management system has demonstrated notable advancements in electronic data capture (EDC) by moving towards digital-enabled trials over 95% of paper-based data entry. Regulatory authorities like Food and Drug Administration (FDA) have mandated that study submissions require to follow the highest-level quality standards.  For the submission of data in the latest standard, CDMS is necessary. Due to the growing clinical trial volume, the CDMS demand is increased. These factors boost the growth of the clinical data management market in the forecast periods.

Restraints:

High Price of Software and Privacy Issues Associated with Data

A clinical data management system involves the collection of data that may cause patient privacy issues, especially in the electronic data capture segment that is responsible for restricting market growth. The CDMS market is also affected due to a lack of qualified personnel to manage complex digital solutions in research teams. The shortage of experienced workers in the clinical sector is restrict the use of sophisticated software in the clinics. Additionally, the software of the clinical data management system is expensive so this software is not affordable for every organization. These are all the factors hindering the growth of the market of CDMS during the analysis year.

Opportunity:

Opportunity in Novel Technology In Clinical Data Management System

Growing research and development of the new technology in the CDMS provide a lucrative opportunity for the clinical data management system market over the forecast period. For instance, Cloud-based clinical metadata repositories (CMDR) are the new technology that assists to standardize clinical trial design and development. The CMDR offers the benefits like regulatory Compliance, standardization of clinical metadata, provide productivity, and cost-efficiency. Another new technology adopted in the CDMS is Artificial Intelligence (AI), is help to rapidly identify the right candidates to accelerate the research and development timelines. AI also detects errors in the data for risk-based management. AI also helps to identify patients’ patterns of behavior, problematic sites, and drug design. In addition to this, the Electronic Clinical Outcome Assessment (eCOA) is also used in CDMS and can automate data entry to ensure data accuracy. This solution enhances patient care through remote assessment. This novel technology helps to increase the demand for clinical data management systems in the healthcare sector that offers the remunerative opportunity for the market of CDMS in the analysis period.

Segmentation Analysis Of Clinical Data Management System (CDMS) Market

By Type, the electronic data capturing systems market is projected to dominate the market over the analysis period. The electronic data capturing system is also referred to as an electronic case report from eCRF. It is a web-based software used in clinical trials to collect, clean, transfer, and process data. For the usage of electronic data capturing in clinical trials, there is no legal or regulatory obligation. It is a novel technology that requires less time to collect data. The EDC system collects the various kind of the data such as demographics, medical history, vital signs, ECOG performance status, electrocardiogram data, biochemistry, hematology, coagulation tests, urinalysis, pregnancy tests, adverse events, concomitant medications, tumor assessments, treatment data, survival follow-up, and death information, and other information. The EDC system hastens the data cleaning process. The data manager can easily analyze the data entered in the system and issue queries to sites to solve discrepancies.  The EDC system consists of advanced features to perform various tasks. The features include automatic query mechanisms, automated coding of medical terms, generation of customized reports, and powerful modules for data cleaning and source data verification. Due to these advanced features and a lot of benefits of the EDC system, there is a growing demand for clinical research sectors.

By Application, Pharma & Biopharmaceutical segment is anticipated to have maximum market share in the market of the clinical data management system. The pharmaceutical and biopharmaceutical industry has one of the maximum research and development expenses in the world. Thus, clinical data management software has increased the demand in this industry. For ensuring the data on medication development collected by pharmaceutical companies, the government depends on the clinical data management system. Due to the prevalence of several chronic disorders, the government of various countries increases their investment in the research and development of new drugs, thus rises the CDMS demand among the pharmaceutical and biopharmaceutical industries which boosts the market of CDMS during the analysis year.

Regional Analysis Of Clinical Data Management System (CDMS) Market

North America is the dominant region in the clinical data management system market. This is owing to the growing demand for standardization data and increasing investment in pharmaceutical firms. The market players in North America focus on research and development of new drugs. E medical answer software market also witnessed rapid growth due to the presence of multiple pharmaceutical organizations in North America. The expansion of the clinical data management market is majorly attributed to the easy accessibility of a variety of patients in the area, and the outsourcing of medical trials. In the North American region, the US country is dominating the market of clinical data management system market owing to the presence of the biggest pharma companies. This increased the demand for clinical data management systems in the pharmaceutical industries which propel the growth of the market in the analysis year.

The Asia Pacific is the second dominating region in the market for clinical data management systems. In the Asia Pacific highest number of pharmaceutical companies. According to Statista, as of 2020, in Vietnam, there were 442 pharmaceutical companies and in Thailand 395 pharma companies. These pharma companies are engaged in the research and development of new drugs. Thus, the clinical data management system has huge demand from market players. Additionally, the growing other healthcare infrastructures, massive patient population, the prevalence of serious illnesses, and growing clinical trials are the key factors involved in the growth of the market. India and China are the dominating countries in this region owing to their population base with a large number of the healthcare sector involves in the research and development of new drug activity that boosts the growth of the clinical data management system market in this region during the forecast period.

Europe has the fastest growth in the CDMS market owing to rising investment in clinical research by various pharmaceutical as well as biopharmaceutical industries. The government of this region increasing its initiatives for the approval of clinical trials. Apart from this growing prevalence of chronic diseases and the rising number of healthcare IT infrastructures in the Europe region supported to the growth of the clinical data management system market in the projected timeframe.

Covid-19 Impact Analysis On Clinical Data Management System (CDMS) Market

COVID-19 began in Wuhan (China) in December 2019 and has since rapidly grown around the globe. In terms of confirmed cases and reported deaths, the US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are among the countries that have been most severely impacted. Because of the lockdowns, travel restrictions, and business closures, COVID-19 has had an impact on the businesses and industries of numerous nations. The covid-19 has had a positive impact on the healthcare system. During the pandemic, the pharmaceutical industries engaged in research and development activity. Thus, growing demand for clinical data management systems in the pharma as well as biopharma industries. The government of various countries increases their initiatives for the development of new drugs. Henceforth, COVID-19 has had a positive impact on the clinical data management system market.

Top Key Players Covered In Clinical Data Management System (CDMS) Market

• Fortress Medical Systems (Minnesota)
• Ofni Systems (US)
• Deep 6 AI (US)
• ACI Clinical (US)
• Perceptive Informatics (US)
• Medidata Rave (US)
• Forte Research Systems (US)
• IBM Watson Health (Cambridge)
• ClinCapture (US)
• Medrio (San Francisco)
• Novaseek Research (South San Francisco), and other major players.

Key Industry Development In The Clinical Data Management System (CDMS) Market

In June 2022, MMS Holdings, a data-focused Contract Research Organization (CRO) declared a strategic partnership with Medidata. The main view of this partnership is to provide clients with a full range of Medidata’s solutions for clinical data management (CDM) and decentralized clinical trial (DCT) technologies which consist of Medidata’s unified platform and Rave EDC.

In April 2022, Ennov acquired MACRO from Elsevier, a supplier of advanced EDC (Electronic Data Capture) software for clinical research. The MACRO serves research institutions in Austria, Ireland, Spain, Sweden, Germany, and Switzerland. This acquisition is expected to help the company offer clinical trial and compliance solutions in the Europe region.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Application

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Clinical Data Management System (CDMS) Market by Type
 5.1 Clinical Data Management System (CDMS) Market Overview Snapshot and Growth Engine
 5.2 Clinical Data Management System (CDMS) Market Overview
 5.3 Paper-based Systems
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Paper-based Systems: Geographic Segmentation
 5.4 Electronic Data Capturing Systems
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Electronic Data Capturing Systems: Geographic Segmentation

Chapter 6: Clinical Data Management System (CDMS) Market by Application
 6.1 Clinical Data Management System (CDMS) Market Overview Snapshot and Growth Engine
 6.2 Clinical Data Management System (CDMS) Market Overview
 6.3 Pharma & Biopharmaceutical
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Pharma & Biopharmaceutical: Geographic Segmentation
 6.4 Medical Device
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Medical Device: Geographic Segmentation
 6.5 Other
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size (2016-2028F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Other: Geographic Segmentation

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Positioning
  7.1.2 Clinical Data Management System (CDMS) Sales and Market Share By Players
  7.1.3 Industry BCG Matrix
  7.1.4 Ansoff Matrix
  7.1.5 Clinical Data Management System (CDMS) Industry Concentration Ratio (CR5 and HHI)
  7.1.6 Top 5 Clinical Data Management System (CDMS) Players Market Share
  7.1.7 Mergers and Acquisitions
  7.1.8 Business Strategies By Top Players
 7.2 FORTRESS MEDICAL SYSTEMS (MINNESOTA)
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Operating Business Segments
  7.2.5 Product Portfolio
  7.2.6 Business Performance
  7.2.7 Key Strategic Moves and Recent Developments
  7.2.8 SWOT Analysis
 7.3 OFNI SYSTEMS (US)
 7.4 DEEP 6 AI (US)
 7.5 ACI CLINICAL (US)
 7.6 PERCEPTIVE INFORMATICS (US)
 7.7 MEDIDATA RAVE (US)
 7.8 FORTE RESEARCH SYSTEMS (US)
 7.9 IBM WATSON HEALTH (CAMBRIDGE)
 7.10 CLINCAPTURE (US)
 7.11 MEDRIO (SAN FRANCISCO)
 7.12 NOVASEEK RESEARCH (SOUTH SAN FRANCISCO)
 7.13 OTHER MAJOR PLAYERS

Chapter 8: Global Clinical Data Management System (CDMS) Market Analysis, Insights and Forecast, 2016-2028
 8.1 Market Overview
 8.2 Historic and Forecasted Market Size By Type
  8.2.1 Paper-based Systems
  8.2.2 Electronic Data Capturing Systems
 8.3 Historic and Forecasted Market Size By Application
  8.3.1 Pharma & Biopharmaceutical
  8.3.2 Medical Device
  8.3.3 Other

Chapter 9: North America Clinical Data Management System (CDMS) Market Analysis, Insights and Forecast, 2016-2028
 9.1 Key Market Trends, Growth Factors and Opportunities
 9.2 Impact of Covid-19
 9.3 Key Players
 9.4 Key Market Trends, Growth Factors and Opportunities
 9.4 Historic and Forecasted Market Size By Type
  9.4.1 Paper-based Systems
  9.4.2 Electronic Data Capturing Systems
 9.5 Historic and Forecasted Market Size By Application
  9.5.1 Pharma & Biopharmaceutical
  9.5.2 Medical Device
  9.5.3 Other
 9.6 Historic and Forecast Market Size by Country
  9.6.1 U.S.
  9.6.2 Canada
  9.6.3 Mexico

Chapter 10: Europe Clinical Data Management System (CDMS) Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Type
  10.4.1 Paper-based Systems
  10.4.2 Electronic Data Capturing Systems
 10.5 Historic and Forecasted Market Size By Application
  10.5.1 Pharma & Biopharmaceutical
  10.5.2 Medical Device
  10.5.3 Other
 10.6 Historic and Forecast Market Size by Country
  10.6.1 Germany
  10.6.2 U.K.
  10.6.3 France
  10.6.4 Italy
  10.6.5 Russia
  10.6.6 Spain
  10.6.7 Rest of Europe

Chapter 11: Asia-Pacific Clinical Data Management System (CDMS) Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 Paper-based Systems
  11.4.2 Electronic Data Capturing Systems
 11.5 Historic and Forecasted Market Size By Application
  11.5.1 Pharma & Biopharmaceutical
  11.5.2 Medical Device
  11.5.3 Other
 11.6 Historic and Forecast Market Size by Country
  11.6.1 China
  11.6.2 India
  11.6.3 Japan
  11.6.4 Singapore
  11.6.5 Australia
  11.6.6 New Zealand
  11.6.7 Rest of APAC

Chapter 12: Middle East & Africa Clinical Data Management System (CDMS) Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 Paper-based Systems
  12.4.2 Electronic Data Capturing Systems
 12.5 Historic and Forecasted Market Size By Application
  12.5.1 Pharma & Biopharmaceutical
  12.5.2 Medical Device
  12.5.3 Other
 12.6 Historic and Forecast Market Size by Country
  12.6.1 Turkey
  12.6.2 Saudi Arabia
  12.6.3 Iran
  12.6.4 UAE
  12.6.5 Africa
  12.6.6 Rest of MEA

Chapter 13: South America Clinical Data Management System (CDMS) Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Type
  13.4.1 Paper-based Systems
  13.4.2 Electronic Data Capturing Systems
 13.5 Historic and Forecasted Market Size By Application
  13.5.1 Pharma & Biopharmaceutical
  13.5.2 Medical Device
  13.5.3 Other
 13.6 Historic and Forecast Market Size by Country
  13.6.1 Brazil
  13.6.2 Argentina
  13.6.3 Rest of SA

Chapter 14 Investment Analysis

Chapter 15 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET COMPETITIVE RIVALRY
TABLE 005. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET THREAT OF NEW ENTRANTS
TABLE 006. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET THREAT OF SUBSTITUTES
TABLE 007. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET BY TYPE
TABLE 008. PAPER-BASED SYSTEMS MARKET OVERVIEW (2016-2028)
TABLE 009. ELECTRONIC DATA CAPTURING SYSTEMS MARKET OVERVIEW (2016-2028)
TABLE 010. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET BY APPLICATION
TABLE 011. PHARMA & BIOPHARMACEUTICAL MARKET OVERVIEW (2016-2028)
TABLE 012. MEDICAL DEVICE MARKET OVERVIEW (2016-2028)
TABLE 013. OTHER MARKET OVERVIEW (2016-2028)
TABLE 014. NORTH AMERICA CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET, BY TYPE (2016-2028)
TABLE 015. NORTH AMERICA CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET, BY APPLICATION (2016-2028)
TABLE 016. N CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET, BY COUNTRY (2016-2028)
TABLE 017. EUROPE CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET, BY TYPE (2016-2028)
TABLE 018. EUROPE CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET, BY APPLICATION (2016-2028)
TABLE 019. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET, BY COUNTRY (2016-2028)
TABLE 020. ASIA PACIFIC CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET, BY TYPE (2016-2028)
TABLE 021. ASIA PACIFIC CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET, BY APPLICATION (2016-2028)
TABLE 022. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET, BY COUNTRY (2016-2028)
TABLE 023. MIDDLE EAST & AFRICA CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET, BY TYPE (2016-2028)
TABLE 024. MIDDLE EAST & AFRICA CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET, BY APPLICATION (2016-2028)
TABLE 025. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET, BY COUNTRY (2016-2028)
TABLE 026. SOUTH AMERICA CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET, BY TYPE (2016-2028)
TABLE 027. SOUTH AMERICA CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET, BY APPLICATION (2016-2028)
TABLE 028. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET, BY COUNTRY (2016-2028)
TABLE 029. FORTRESS MEDICAL SYSTEMS (MINNESOTA): SNAPSHOT
TABLE 030. FORTRESS MEDICAL SYSTEMS (MINNESOTA): BUSINESS PERFORMANCE
TABLE 031. FORTRESS MEDICAL SYSTEMS (MINNESOTA): PRODUCT PORTFOLIO
TABLE 032. FORTRESS MEDICAL SYSTEMS (MINNESOTA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 032. OFNI SYSTEMS (US): SNAPSHOT
TABLE 033. OFNI SYSTEMS (US): BUSINESS PERFORMANCE
TABLE 034. OFNI SYSTEMS (US): PRODUCT PORTFOLIO
TABLE 035. OFNI SYSTEMS (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 035. DEEP 6 AI (US): SNAPSHOT
TABLE 036. DEEP 6 AI (US): BUSINESS PERFORMANCE
TABLE 037. DEEP 6 AI (US): PRODUCT PORTFOLIO
TABLE 038. DEEP 6 AI (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 038. ACI CLINICAL (US): SNAPSHOT
TABLE 039. ACI CLINICAL (US): BUSINESS PERFORMANCE
TABLE 040. ACI CLINICAL (US): PRODUCT PORTFOLIO
TABLE 041. ACI CLINICAL (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 041. PERCEPTIVE INFORMATICS (US): SNAPSHOT
TABLE 042. PERCEPTIVE INFORMATICS (US): BUSINESS PERFORMANCE
TABLE 043. PERCEPTIVE INFORMATICS (US): PRODUCT PORTFOLIO
TABLE 044. PERCEPTIVE INFORMATICS (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 044. MEDIDATA RAVE (US): SNAPSHOT
TABLE 045. MEDIDATA RAVE (US): BUSINESS PERFORMANCE
TABLE 046. MEDIDATA RAVE (US): PRODUCT PORTFOLIO
TABLE 047. MEDIDATA RAVE (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 047. FORTE RESEARCH SYSTEMS (US): SNAPSHOT
TABLE 048. FORTE RESEARCH SYSTEMS (US): BUSINESS PERFORMANCE
TABLE 049. FORTE RESEARCH SYSTEMS (US): PRODUCT PORTFOLIO
TABLE 050. FORTE RESEARCH SYSTEMS (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. IBM WATSON HEALTH (CAMBRIDGE): SNAPSHOT
TABLE 051. IBM WATSON HEALTH (CAMBRIDGE): BUSINESS PERFORMANCE
TABLE 052. IBM WATSON HEALTH (CAMBRIDGE): PRODUCT PORTFOLIO
TABLE 053. IBM WATSON HEALTH (CAMBRIDGE): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. CLINCAPTURE (US): SNAPSHOT
TABLE 054. CLINCAPTURE (US): BUSINESS PERFORMANCE
TABLE 055. CLINCAPTURE (US): PRODUCT PORTFOLIO
TABLE 056. CLINCAPTURE (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. MEDRIO (SAN FRANCISCO): SNAPSHOT
TABLE 057. MEDRIO (SAN FRANCISCO): BUSINESS PERFORMANCE
TABLE 058. MEDRIO (SAN FRANCISCO): PRODUCT PORTFOLIO
TABLE 059. MEDRIO (SAN FRANCISCO): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. NOVASEEK RESEARCH (SOUTH SAN FRANCISCO): SNAPSHOT
TABLE 060. NOVASEEK RESEARCH (SOUTH SAN FRANCISCO): BUSINESS PERFORMANCE
TABLE 061. NOVASEEK RESEARCH (SOUTH SAN FRANCISCO): PRODUCT PORTFOLIO
TABLE 062. NOVASEEK RESEARCH (SOUTH SAN FRANCISCO): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 062. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 063. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 064. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 065. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET OVERVIEW BY TYPE
FIGURE 012. PAPER-BASED SYSTEMS MARKET OVERVIEW (2016-2028)
FIGURE 013. ELECTRONIC DATA CAPTURING SYSTEMS MARKET OVERVIEW (2016-2028)
FIGURE 014. CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET OVERVIEW BY APPLICATION
FIGURE 015. PHARMA & BIOPHARMACEUTICAL MARKET OVERVIEW (2016-2028)
FIGURE 016. MEDICAL DEVICE MARKET OVERVIEW (2016-2028)
FIGURE 017. OTHER MARKET OVERVIEW (2016-2028)
FIGURE 018. NORTH AMERICA CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 019. EUROPE CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 020. ASIA PACIFIC CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 021. MIDDLE EAST & AFRICA CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. SOUTH AMERICA CLINICAL DATA MANAGEMENT SYSTEM (CDMS) MARKET OVERVIEW BY COUNTRY (2016-2028)